Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kirkman

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Obstetrics and Gynecology|July 1, 1978
The large fetus. Management and outcomeI M Golditch, K Kirkman
Journal of Pharmaceutical Sciences|July 1, 1980
Macro- and micromethods for high-performance liquid chromatographic analysis of oxaprozin in plasmaS L McHugh, S K Kirkman, J A Knowles
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 1998
Isolation and identification of bromfenac glucoside from rat bileS K Kirkman, M Y Zhang, P M Horwatt, et al.
American Journal of Botany|June 15, 2011
Productivity and species richness across an environmental gradient in a fire-dependent ecosystemL K Kirkman, R J Mitchell, R C Helton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1978
Disposition of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin) in beagle dogs and rhesus monkeysF W Janssen, S K Kirkman, J A Knowles, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albuminH W Ruelius, S K Kirkman, E M Young, et al.
Organic & Biomolecular Chemistry|November 14, 2008
Synthesis of 3-(carboxyarylalkyl)imidazo[2,1-f][1,2,4]triazines as potential inhibitors of AMP deaminaseJoseph K Kirkman, Stephen D Lindell, Simon Maechling, et al.
Ecology|November 19, 2016
Productivity and species richness in longleaf pine woodlands: resource-disturbance influences across an edaphic gradientL K Kirkman, L M Giencke, R S Taylor, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1982
Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-o-acyl glucuronideF W Janssen, S K Kirkman, C Fenselau, et al.
Clinical Pharmacology and Therapeutics|March 1, 1980
Metabolism and kinetics of oxaprozin in normal subjectsF W Janssen, W J Jusko, S T Chiang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Obstetrics and Gynecology|July 1, 1978
The large fetus. Management and outcomeI M Golditch, K Kirkman
Journal of Pharmaceutical Sciences|July 1, 1980
Macro- and micromethods for high-performance liquid chromatographic analysis of oxaprozin in plasmaS L McHugh, S K Kirkman, J A Knowles
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 1998
Isolation and identification of bromfenac glucoside from rat bileS K Kirkman, M Y Zhang, P M Horwatt, et al.
American Journal of Botany|June 15, 2011
Productivity and species richness across an environmental gradient in a fire-dependent ecosystemL K Kirkman, R J Mitchell, R C Helton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1978
Disposition of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin) in beagle dogs and rhesus monkeysF W Janssen, S K Kirkman, J A Knowles, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albuminH W Ruelius, S K Kirkman, E M Young, et al.
Organic & Biomolecular Chemistry|November 14, 2008
Synthesis of 3-(carboxyarylalkyl)imidazo[2,1-f][1,2,4]triazines as potential inhibitors of AMP deaminaseJoseph K Kirkman, Stephen D Lindell, Simon Maechling, et al.
Ecology|November 19, 2016
Productivity and species richness in longleaf pine woodlands: resource-disturbance influences across an edaphic gradientL K Kirkman, L M Giencke, R S Taylor, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1982
Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-o-acyl glucuronideF W Janssen, S K Kirkman, C Fenselau, et al.
Clinical Pharmacology and Therapeutics|March 1, 1980
Metabolism and kinetics of oxaprozin in normal subjectsF W Janssen, W J Jusko, S T Chiang, et al.
Pageof 2